معرفی
Robert Kronstrand is an Adjunct Professor at Linköping University (LiU) within the Department of Biomedical and Clinical Sciences (BKV), affiliated with the Division of Clinical Chemistry and Pharmacology (KKF). His research focuses on forensic toxicology, pharmacology, and clinical chemistry, particularly addressing new psychoactive substances (NPS) and their effects. He has contributed to developing rapid methods for classifying NPS and analyzing synthetic cannabinoids like HHC and HHC-P. His work bridges clinical and forensic applications, including drug metabolism studies, intensive care drug safety, and toxicology in legal contexts (e.g., DUID cases).
Key research areas include the epidemiology of NPS, cannabinoid receptor activation mechanisms, and optimizing drug dosages in critical care settings. A notable project involves a SEK 13 million grant to advance forensic investigations using AI and metabolomics. His interdisciplinary collaborations span clinical chemistry, pharmacology, and forensic science, with publications in journals like Basic & Clinical Pharmacology & Toxicology and Journal of Analytical Toxicology.
His expertise includes analytical methods for drug detection, metabolite quantification, and understanding drug interactions in human systems. While no awards are explicitly listed, his contributions to NPS classification and forensic methodologies reflect significant impact in toxicology and public health.
